A prospective highlight on exosomal nanoshuttles and cancer immunotherapy and vaccination
/in Dendritic Cells, Exosome, International Publications /von 2015-09-10 / Bioimpacts 2015;5(3):117-22Immunotherapy of Brain Tumors
/in Brain Tumors in Children, Dendritic Cells, International Publications /von 2015-09-04 / Prog Tumor Res 2015;42:11-21Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2015-09-01 / PLoS ONE 2015;10(9):e0136911Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2015-08-27 / J. Neurooncol. 2015 Oct;125(1):65-74Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45)
/in Breast Cancer, Dendritic Cells, International Publications /von 2015-08-13 / Clin Transl Oncol 2016 Jan;18(1):82-7Dendritic cell-based immunotherapy targeting Wilms‘ tumor 1 in patients with recurrent malignant glioma
/in Dendritic Cells, Glioblastoma, International Publications /von 2015-08-07 / J. Neurosurg. 2015 Oct;123(4):989-97Enhancement of the Immunostimulatory Functions of Ex Vivo-Generated Dendritic Cells from Early-Stage Colon Cancer Patients by Consecutive Exposure to Low Doses of Sequential-Kinetic-Activated IL-4 and IL-12. A Preliminary Study
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2015-08-01 / Transl Oncol 2015 Aug;8(4):327-38Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2015-07-21 / J Immunother Cancer 2015;3:32Vaccination of multiple myeloma: Current strategies and future prospects
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2015-06-18 / Crit. Rev. Oncol. Hematol. 2015 Nov;96(2):339-54
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de